​

Cassava Sciences (SAVA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Cassava Sciences Revenue Highlights

0

Latest Revenue (Q)

$840.00K

Cassava Sciences Revenue by Period

Cassava Sciences Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$-1.80K100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31--100.00%
2013-12-31$41.12M277.58%
2012-12-31$10.89M-5.17%
2011-12-31$11.48M-31.68%
2010-12-31$16.81M-18.26%
2009-12-31$20.56M-67.73%
2008-12-31$63.73M-3.42%
2007-12-31$65.98M22.38%
2006-12-31$53.92M961.38%
2005-12-31$5.08M100.00%
2004-12-31-100.00%
2003-12-31--100.00%
2002-12-31$114.00K100.00%
2001-12-31--100.00%
2000-12-31$1.00-
1999-12-31$1.00-

Cassava Sciences generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Cassava Sciences Revenue by Quarter

DateRevenueChange
2025-09-30$840.00K100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--100.00%
2019-09-30$104.00100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31--100.00%
2013-12-31$35.24M1700.00%
2013-09-30$1.96M-0.05%
2013-06-30$1.96M0.05%
2013-03-31$1.96M-20.66%
2012-12-31$2.47M-9.43%
2012-09-30$2.73M0.04%
2012-06-30$2.72M-8.38%
2012-03-31$2.97M8.23%
2011-12-31$2.75M-0.07%
2011-09-30$2.75M-0.11%
2011-06-30$2.75M-14.96%
2011-03-31$3.24M-59.60%
2010-12-31$8.01M176.65%
2010-09-30$2.90M9.00%
2010-06-30$2.66M-18.25%
2010-03-31$3.25M-12.87%
2009-12-31$3.73M-0.90%
2009-09-30$3.76M-39.66%
2009-06-30$6.24M-8.76%
2009-03-31$6.83M-17.09%
2008-12-31$8.24M-72.79%
2008-09-30$30.29M187.23%
2008-06-30$10.55M-27.95%
2008-03-31$14.64M4.15%
2007-12-31$14.06M-11.09%
2007-09-30$15.81M-

Cassava Sciences generated $840.00K in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Cassava Sciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALECAlector$100.56M$3.26M
FATEFate Therapeutics$13.63M$1.91M
MOLNMolecular Partners$7.04M$2.74M
ELTXElicio Therapeutics--
NKTXNkarta--
SAVACassava Sciences-$840.00K
RANIRani Therapeutics--
CRDFCardiff Oncology-$121.00K
PEPGPepGen--
MISTMilestone Pharmaceuticals--

SAVA Revenue FAQ

What is Cassava Sciences’s yearly revenue?

Cassava Sciences's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. SAVA's yearly revenue for 2022 was $-1.8K, representing an increase of 100.00% compared to 2021.

What is Cassava Sciences’s quarterly revenue?

Cassava Sciences's quarterly revenue for Q3 2025 was $840K, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). SAVA's quarterly revenue for Q1 2025 was $0, a 100.00% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Cassava Sciences’s revenue growth rate?

Cassava Sciences's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was 0%.